NeuroStar Advanced Therapy System
Commercial- Indications
- Major Depressive Disorder, Depression
Company intelligence / Profile preview
Neuronetics
Malvern, Pennsylvania, United Statesneurostar.com ↗
- Ownership
- Public · STIM
- Employees
- ~250
- Development stage
- Commercial
01
Overview
Neuronetics’ flagship product, the NeuroStar Advanced Therapy System for Mental Health, delivers transcranial magnetic stimulation (TMS) and has been FDA-cleared for treatment-resistant major depressive disorder. It has delivered over 7.4 million treatments to more than 200,000 patients and boasts the largest clinical data set and outcomes registry in TMS therapy for depression. The company continues to expand its clinical evidence base and explore new indications[1][6].
- Therapeutic areas
- Psychiatry
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Teijin Pharma (exclusive distribution agreement for Japan)
04
Financials
- Market cap
- $211.5M
- Total revenue
- $41.6M
- Enterprise value
- $278.6M
Beyond the preview
Go deeper on Neuronetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neuronetics.